ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced connectivity with an additional electronic health record (EHR) solution and a cardiac rhythm management (CRM) data management system. The company’s Merlin.net™ Patient Care Network (PCN), an Internet-based repository of patient and implantable device data, is now fully integrated with GE Healthcare’s Centricity EMR, as well as Scottcare’s OneView CRM device management system. St. Jude Medical customers using these EHR solutions have the opportunity to seamlessly integrate their EHR systems with the Merlin.net PCN.
Clinicians using St. Jude Medical products are already benefiting from these new connections:
“Integrating GE’s Centricity EMR with Merlin.net was a major milestone for taking our remote patient management to the next level. We are now able to achieve greater efficiency through simplified clinic workflows and by having complete patient information in one electronic record,” said Dr. Dan Goldman, The Cardiology Center, Delray Beach, Fla.
“We chose ScottCare OneView as our device management solution because it truly communicates equally with all device vendors, and specifically, it works well with Merlin.net. The smooth integration with all device companies and the availability of complete information, whether discrete data or PDFs, made this the right solution for our clinic’s needs,” said LaNita Hobby, R.N, Device Clinic Supervisor, Little Rock Cardiology, Little Rock, Ark.
St. Jude Medical will be demonstrating EHR interoperability with Merlin.net PCN at the company’s booth #702 during Heart Rhythm 2011.
About the Merlin.net Patient Care Network (PCN)
Implantable cardiac devices are designed to capture and record information about patient heart rhythms and device performance that is vital to patient care. Merlin.net PCN organizes this information for fast analysis and easy review and allows data to be sent directly to a clinic's or a hospital's EHR system so the data are included in the patient's comprehensive personal health record.
With immediate access to patient information through the secure Merlin.net PCN website, physicians can remotely monitor and assess patient device data and determine the level of care needed. Alert notification delivery times can be customized to fit in with physician determined clinic hours, including any after-hours processes the clinic might provide.
The data transferred to the Merlin.net PCN is fully encrypted and meets or exceeds all applicable national data privacy and security requirements in every country where the system is used. In addition, BSI Management Systems, an international standards, testing, registration and certification organization, has awarded St. Jude Medical the information security certification ISO/IEC 27001:2005. This ISO certification, a stringent worldwide information security standard, recognizes that St. Jude Medical's Merlin.net PCN has established processes and standards that maintain the strictest levels of confidentiality, integrity and availability for its customers. The Merlin.net PCN is the first medical device data network to be recognized with this certification.
About St. Jude Medical
St. Jude Medical develops medical technology and services that focus on putting more control into the hands of those who treat cardiac, neurological and chronic pain patients worldwide. The company is dedicated to advancing the practice of medicine by reducing risk wherever possible and contributing to successful outcomes for every patient. St. Jude Medical is headquartered in St. Paul, Minn. and has four major focus areas that include: cardiac rhythm management, atrial fibrillation, cardiovascular and neuromodulation. For more information, please visit sjm.com.
Forward-Looking Statements
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Such forward-looking statements include the expectations, plans and prospects for the Company, including potential clinical successes, anticipated regulatory approvals and future product launches, and projected revenues, margins, earnings and market shares. The statements made by the Company are based upon management’s current expectations and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include market conditions and other factors beyond the Company’s control and the risk factors and other cautionary statements described in the Company’s filings with the SEC, including those described in the Risk Factors and Cautionary Statements sections of the Company’s Annual Report on Form 10-K for the fiscal year ended January 1, 2011. The Company does not intend to update these statements and undertakes no duty to any person to provide any such update under any circumstance.